Professor of Medicine
University of Pittsburgh
Pittsburgh, PA, United States
Dr. Yohei Doi is Professor of Medicine and Director of the Center for Innovative Antimicrobial Therapy at the University of Pittsburgh and Professor of Microbiology and Infectious Diseases at Fujita Health University. His research focuses on mechanisms of antimicrobial resistance in highly drug-resistant Gram-negative bacterial pathogens and devising ways to overcome them. He has authored over 250 articles in peer-reviewed journals and mentored over 30 students and trainees in his laboratory. He currently chairs the Gram-negative committee of the Antibacterial Resistance Leadership Group.
Astellas (Individual(s) Involved: Self): Grant/Research Support; AstraZeneca (Individual(s) Involved: Self): Speakers' bureau; bioMerieux (Individual(s) Involved: Self): Consultant, Speakers' bureau; Chugai (Individual(s) Involved: Self): Consultant; Entasis (Individual(s) Involved: Self): Consultant; FujiFilm (Individual(s) Involved: Self): Advisor or Review Panel member; Gilead (Individual(s) Involved: Self): Consultant; GSK (Individual(s) Involved: Self): Consultant; Kanto Chemical (Individual(s) Involved: Self): Grant/Research Support; MSD (Individual(s) Involved: Self): Speaking Fee; Pfizer (Individual(s) Involved: Self): Grant/Research Support; Shionogi (Individual(s) Involved: Self): Grant/Research Support, Speakers' bureau; Teijin Healthcare (Individual(s) Involved: Self): Speakers' bureau; VenatoRx (Individual(s) Involved: Self): Consultant
CTS-08 - COVID-19 Update in Japan
Wednesday, September 29, 2021
7:00 PM - 8:00 PM EDT
85 - Public-private Partnerships to Revive Future Antibiotic Development and Access
Friday, October 1, 2021
11:30 AM - 12:45 PM EDT
90 - Therapeutic Options for MDR Gram-negatives
Friday, October 1, 2021
2:45 PM - 4:00 PM EDT
127 - Pathogen-specific Clinical Trials: Promise and Practical Considerations
Saturday, October 2, 2021
10:00 AM - 11:15 AM EDT